Strängnäs, Sweden

Mikael Bisrat

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Södertälje, SE (2002)
  • Strängnäs, SE (2002 - 2022)

Company Filing History:


Years Active: 2002-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mikael Bisrat

Introduction

Mikael Bisrat is a notable inventor based in Strängnäs, Sweden. He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work focuses on developing innovative solutions for medical treatments, particularly in the areas of pain relief and cancer therapy.

Latest Patents

Among his latest patents is a lozenge comprising micronized benzocaine and polyethylene glycol. This invention relates to a lozenge that includes micronized benzocaine, at least one dissolution enhancer, and one or more excipients, aimed at treating sore throat. Another significant patent is for picropodophyllin polymorph C and its use in cancer therapy. This invention involves novel polymorphs of picropodophyllin, methods for preparing these polymorphs, and pharmaceutical compositions that utilize them in cancer treatment.

Career Highlights

Mikael has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Axelar AB. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Mikael has collaborated with several professionals in his field, including Saeed Moshashaee and Håkan Nyqvist. These collaborations have likely enhanced his research and development efforts.

Conclusion

Mikael Bisrat's innovative work in pharmaceuticals demonstrates his commitment to improving medical treatments through his inventions. His contributions, particularly in pain relief and cancer therapy, highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…